• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CELG:US

87.1600 USD 0.9700 1.13%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Celgene Corp (CELG)

Open: 86.2600 Day's Range: 85.8781 - 87.4600 Volume: 3,544,302
Previous Close: 86.1900 52wk Range: 65.7601 - 90.5000 1-Yr Rtn: +21.11%

Stock Chart for CELG

No chart data available.
  • CELG:US 87.1600
  • 1D
  • 1M
  • 1Y
86.1900
Interactive CELG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CELG

Current P/E Ratio (ttm) 35.3563
Estimated P/E(12/2014) 23.7752
Relative P/E vs. SPX 1.9541
Earnings Per Share (USD) (ttm) 2.4652
Est. EPS (USD) (12/2014) 3.6660
Est. PEG Ratio 0.9251
Market Cap (M USD) 69,800.66
Shares Outstanding (M) 800.83
30 Day Average Volume 5,086,047
Price/Book (mrq) 15.5639
Price/Sale (ttm) 10.0882
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CELG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CELG

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J Hugin "Bob"Chairman/President/CEOMark J AllesExec VP/Head:Hematology
Jacqualyn A Fouse "Jackie"Exec VP/CFOPeter N KelloggExecutive Vice President
More Company Profile & Key Executives for CELG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil